Press Release
Eclipsebio is the exclusive license holder to patents covering key aspects of Ribo-Seq technology developed by inventors Weismann and Ingolia at the University of California, San Fransisco (UCSF) SAN DIEGO, July 27, 2023 /PRNewswire/ — Eclipsebio, a leading provider of innovative RNA analysis solutions, announces the launch of its proprietary eRibo Pro™ service, an all-inclusive offering to […]
Press Release
Eclipsebio Launches eSHAPE™ Product Family to Provide RNA Structure Probing at AGBT 2023 Eclipsebio’s eSHAPE™ product family is a combination of kits, services, and databases, that facilitates the study of RNA secondary structure in both in vitro and in cellulo conditions SAN DIEGO, February 7, 2023 – Eclipse Bioinnovations (Eclipsebio),a leading RNA genomics company developing […]
Press Release
SAN DIEGO, Sept. 27, 2022 /PRNewswire/ — Eclipse Bioinnovations, Inc. (Eclipsebio), a leading RNA genomics company developing and commercializing novel, data-driven technologies that interrogate RNA, today announced the completion of exclusive and co-exclusive licenses for intellectual property (IP) related to RNA structure probing, ribosome occupancy, and RNA modifications. This IP supports three key product suites, m6A-eCLIP™ for profiling m6A […]
Press Release
SAN DIEGO, March 15, 2022 /PRNewswire/ — Eclipse Bioinnovations, Inc. (Eclipsebio), the leading RNA genomics company developing and commercializing novel, data-driven technologies that interrogate RNA, today announced the close of an oversubscribed $14 million Series A financing. The financing was co-led by Alexandria Venture Investments and iGlobe, with participation from Photon Venture Alpha and Phoenix Venture Partners. […]
